Axcella Health Inc. (AXLA)
Dec 29, 2023 - AXLA was delisted (reason: company dissolved)
0.4009
0.00 (0.00%)
Inactive · Last trade price on Dec 29, 2023
Axcella Health Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Axcella Health.
Price Target: n/a
Analyst Consensus: Hold
No price target forecast data available
Analyst Ratings
According to 1 stock analyst, the rating for Axcella Health is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '22 | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 1 | 0 | 0 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 3 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 16, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $150 → $50 | Buy → Hold | Downgrades | $150 → $50 | +12,371.94% | Dec 16, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $175 → $125 | Strong Buy | Maintains | $175 → $125 | +31,079.85% | Nov 2, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $250 | Strong Buy | Maintains | $200 → $250 | +62,259.69% | Oct 3, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.10
from -1.52
EPS Next Year
-5.10
from -5.10
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -5.25 | -5.25 | -5.51 |
| Avg | -5.10 | -5.10 | -5.36 |
| Low | -4.90 | -4.90 | -5.15 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.